Personalized Therapy Study - Attain Stability Quad Post-Approval Study

Inclusion Criteria:

• Patient or legally authorized representative provides written authorization and/orconsent per institution and geographical requirements

• Patient has or is intended to receive or be treated with a Model 4798 lead and aMedtronic CRT device

• Patient within 30 days of therapy received at the time of their initial PSR platformenrollment

Exclusion Criteria:

• Patient who is, or is expected to be inaccessible for follow-up

• Patient with exclusion criteria required by local law

• Patient is currently enrolled in or plans to enroll in any concurrent drug and/ordevice study that may confound results